IBOV 167,537.95 ▼ 1.34% COLCAP 2,452.46 — — IPC MEX 69,154.17 ▼ 1.75% MERVAL 2,848,945 — — USD/BRL5.85▲ 1.14% USD/MXN18.86▲ 0.04% USD/CLP1,007▲ 1.47% USD/COP3,342▲ 1.05% USD/PEN3.41▲ 0.05% USD/ARS1,559▼ 0.02% USD/UYU40.61▲ 3.19% USD/PYG6,212▲ 2.85% USD/BOB11.64▲ 3.02% USD/DOP60.01▼ 0.48% USD/CRC441.73▲ 2.49% USD/GTQ7.64▲ 3.23% USD/HNL26.89▼ 0.14% USD/NIO36.62▲ 0.26% USD/VES913.46▼ 0.22% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.39▲ 2.28% USD/TTD6.70▲ 1.98% EUR/BRL6.42▲ 1.12% BRENT 89.61 ▼ 2.54% WTI 82.60 ▼ 0.79% IRON ORE 161.91 — — COPPER 5.65 ▼ 0.11% GOLD 3,729 ▼ 0.36% SILVER 44.97 ▼ 0.06% SOY 1,219 ▲ 0.18% CORN 447.50 ▲ 2.76% WHEAT 585.75 ▲ 2.76% COFFEE 281.30 ▼ 1.85% SUGAR 18.07 ▲ 0.17% ORANGE JUICE 129.10 ▼ 4.37% COTTON 79.60 ▲ 6.18% COCOA 4,870 ▼ 3.18% BEEF 219.90 ▲ 0.51% CATTLE 336.85 ▲ 0.38% LITHIUM 55.57 ▼ 1.51% PETR4 43.17 ▼ 1.84% VALE3 59.00 ▼ 2.22% ITUB4 40.19 ▼ 1.71% BBDC4 14.08 ▼ 2.29% ABEV3 16.07 ▲ 0.88% BBAS3 14.12 ▼ 3.42% B3SA3 14.30 ▼ 2.39% WEGE3 51.38 ▲ 0.45% PRIO3 61.87 ▼ 3.27% SUZB3 55.60 ▲ 0.38% RENT3 29.45 ▼ 0.71% AZZA3 15.78 ▲ 0.90% CSAN3 3.13 ▼ 3.69% RAIZ4 16.80 ▼ 9.14% PCAR3 2.99 ▲ 3.46% GMAT3 4.05 ▼ 3.11% PSSA3 44.66 ▼ 2.74% CVCB3 0.78 — 0.00% POSI3 3.17 ▲ 1.28% SLCE3 17.88 ▼ 1.00% NATU3 4.78 ▲ 0.63% BRKM5 2.63 ▼ 4.36% RANI3 8.07 ▼ 1.82% IBOV 167,537.95 ▼ 1.34% COLCAP 2,452.46 — — IPC MEX 69,154.17 ▼ 1.75% MERVAL 2,848,945 — — USD/BRL 5.85 ▼ 0.62% USD/MXN 18.86 ▲ 0.02% USD/CLP 1,007 ▲ 1.47% USD/COP 3,342 ▲ 1.05% USD/PEN 3.41 ▲ 0.05% USD/ARS 1,559 ▼ 0.02% USD/UYU 40.61 ▲ 3.19% USD/PYG 6,212 ▲ 2.85% USD/BOB 11.64 ▲ 3.02% USD/DOP 60.01 ▼ 0.32% USD/CRC 441.73 ▲ 2.49% USD/GTQ 7.64 ▲ 3.23% USD/HNL 26.89 ▼ 0.14% USD/NIO 36.62 ▲ 0.26% USD/VES 913.46 ▼ 0.35% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.39 ▲ 2.28% USD/TTD 6.70 ▲ 2.24% EUR/BRL 6.42 ▲ 1.12% BRENT 89.61 ▼ 2.54% WTI 82.60 ▼ 0.79% IRON ORE 161.91 — — COPPER 5.65 ▼ 0.11% GOLD 3,729 ▼ 0.36% SILVER 44.97 ▼ 0.06% SOY 1,219 ▲ 0.18% CORN 447.50 ▲ 2.76% WHEAT 585.75 ▲ 2.76% COFFEE 281.30 ▼ 1.85% SUGAR 18.07 ▲ 0.17% ORANGE JUICE 129.10 ▼ 4.37% COTTON 79.60 ▲ 6.18% COCOA 4,870 ▼ 3.18% BEEF 219.90 ▲ 0.51% CATTLE 336.85 ▲ 0.38% LITHIUM 55.57 ▼ 1.51% PETR4 43.17 ▼ 1.84% VALE3 59.00 ▼ 2.22% ITUB4 40.19 ▼ 1.71% BBDC4 14.08 ▼ 2.29% ABEV3 16.07 ▲ 0.88% BBAS3 14.12 ▼ 3.42% B3SA3 14.30 ▼ 2.39% WEGE3 51.38 ▲ 0.45% PRIO3 61.87 ▼ 3.27% SUZB3 55.60 ▲ 0.38% RENT3 29.45 ▼ 0.71% AZZA3 15.78 ▲ 0.90% CSAN3 3.13 ▼ 3.69% RAIZ4 16.80 ▼ 9.14% PCAR3 2.99 ▲ 3.46% GMAT3 4.05 ▼ 3.11% PSSA3 44.66 ▼ 2.74% CVCB3 0.78 — 0.00% POSI3 3.17 ▲ 1.28% SLCE3 17.88 ▼ 1.00% NATU3 4.78 ▲ 0.63% BRKM5 2.63 ▼ 4.36% RANI3 8.07 ▼ 1.82%
since 2009
Thursday, November 19, 2026

Bain and Advent Team Up on a Fresh Bid for Brazil’s Amil

By · · 5 min read
Bain and Advent Team Up on a Fresh Bid for Brazil's Amil
Photo: Marcosleal, CC BY-SA 3.0, via Wikimedia Commons

Economy

Key Facts

—The move. Bain Capital has teamed with fellow buyout firm Advent on a new proposal for Amil, one of Brazil’s largest health insurers, according to Estadao.
—The seller. Owner Jose Seripieri Filho is said to be open to selling a stake while keeping control.
—The asset. Amil is Brazil’s fourth-largest insurer, with about 5.4 million members, 31 hospitals and revenue near R$26 billion (US$5.0 billion).
—The history. Seripieri bought Amil from UnitedHealth in late 2023 for about R$11 billion (US$2.1 billion), most of it assumed debt.
—The catch. Its individual-plans book has been deeply loss-making, making it a turnaround play rather than a clean asset.
—The hurdles. Any deal would need clearance from the health regulator, the ANS, and the antitrust watchdog, the CADE.

Two global private-equity firms have joined forces to chase Amil, reviving foreign interest in one of Brazil’s largest but most troubled health insurers.

Free daily brief — no card needed
Get every Markets story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

Bain Capital has teamed up with Advent on a fresh proposal for the insurer, according to the Broadcast column of the newspaper Estadao. Both firms circled Amil separately during its last sale, in 2023, and are now said to be working together.

The owner, Jose Seripieri Filho, is reported to be willing to sell a stake while keeping control. That stance, if it holds, points to a deal closer to a partnership than an outright takeover.

Private-equity firms typically prefer full control, which lets them reshape management, cut costs and reset strategy without needing the seller’s approval at every turn. A minority stake with the founder still in charge is less common, though it can work when the owner brings industry relationships or regulatory credibility that a foreign fund cannot easily replicate.

Why private equity wants Amil

Amil is a heavyweight — Brazil’s fourth-largest health operator, with roughly 5.4 million members, 31 hospitals and 28 clinics, and revenue near R$26 billion (US$5.0 billion).

It is also a fixer-upper, an insurer that has bled money for years on its individual-plans book, a segment whose pricing no longer covers rising medical costs — exactly the kind of turnaround that buyout funds are built to run.

Individual health plans in Brazil are policies sold directly to consumers, rather than through employers, and regulators tightly control how much insurers can raise premiums each year. When medical inflation runs faster than allowed price increases, insurers lose money on every claim, which is what happened to Amil and why UnitedHealth wanted out.

Bain knows the terrain, having backed NotreDame Intermedica, later merged into Hapvida, before cashing out; both Bain and Advent have long tracked Brazil’s consolidating private-health market.

Such deals usually come with an operator — in Brazil’s recent health-insurance turnarounds, funds have leaned on executives like Irlau Machado Filho, who ran the Bain-backed NotreDame Intermedica, to cut costs and reset pricing.

OAW6B7J37ZMXZHJFSEZ3UNK7KM
Bain and Advent Team Up on a Fresh Bid for Brazil’s Amil.

From UnitedHealth to a new auction

Amil has changed hands before — UnitedHealth bought about 90 percent of it for US$4.9 billion in 2012, then spent years trying to leave Brazil, where its individual plans kept losing money.

The asset has deep roots — Amil was built by the late Edson Bueno, whose family later founded the diagnostics group Dasa, before UnitedHealth absorbed it in what was then one of Brazil’s biggest foreign acquisitions.

In late 2023, Seripieri, the founder of Qualicorp and an ally of President Lula, took it off UnitedHealth’s hands for about R$11 billion (US$2.1 billion). Only R$2 billion (US$390 million) of that was equity, with the rest, roughly R$9 billion (US$1.7 billion), assumed liabilities, much of it tax and litigation.

Since then he has reshaped it, including a 2025 deal that folded Amil’s hospitals into a venture with the diagnostics group Dasa. A sale of a stake to Bain and Advent would be the next step in carving value from a business bought cheaply and as-is.

The wider sector explains the interest, with Brazil’s private-health market consolidating around a few large groups while medical-cost inflation punishes standalone individual plans — the very weakness dragging on Amil, which buyers now frame as fixable rather than failing.

Consolidation in this context means fewer, bigger players absorbing smaller insurers to spread fixed costs, negotiate harder with hospitals and laboratories, and gain pricing power with regulators. The question is whether scale alone can overcome the structural mismatch between capped premiums and rising claims, or whether deeper reform of Brazil’s individual-plan rules will be needed.

Nothing is settled: the terms have not been disclosed, the companies typically decline to comment on market talk, and any transaction would face scrutiny from Brazil’s health and antitrust regulators before it could close. A change of control in health insurance is especially sensitive in Brazil, where regulators guard continuity of care for millions of members.

The ANS, Brazil’s health-insurance regulator, reviews ownership changes to ensure new owners can meet capital requirements and maintain service levels, while CADE, the antitrust authority, checks whether a deal would reduce competition or harm consumers. Both agencies can block, delay or impose conditions on transactions, adding months to any closing timeline.

Frequently Asked Questions

What is Amil?

Amil is one of Brazil’s largest health insurers and hospital operators, ranking fourth by market share with around 5.4 million members, 31 hospitals and 28 clinics. It earns revenue near R$26 billion (US$5.0 billion) a year, but its individual-plans business has been heavily loss-making, which has shaped every attempt to sell or restructure it.

Who is trying to buy it?

According to Estadao’s Broadcast column, the private-equity firms Bain Capital and Advent have teamed up on a new proposal. Both pursued Amil separately during its 2023 sale, and the current owner, Jose Seripieri Filho, is reported to be open to selling a stake while keeping control.

How did the current owner acquire Amil?

Jose Seripieri Filho, founder of the health-plan administrator Qualicorp, bought Amil from UnitedHealth in late 2023 for about R$11 billion (US$2.1 billion). Only R$2 billion (US$390 million) was equity, with the rest assumed liabilities, in an as-is deal that let UnitedHealth exit Brazil after years of losses.

Connected Coverage

› Dasa’s Q1 2025: Leaner Debt, Bolder Healthcare Ambitions

› Brazil’s Corporate Debt Crisis Hits 10% of Credit

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.

Read More from The Rio Times

RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “US Embassy warns Americans of Colombia strike Thursday”

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.